Novelix Pharma Allots 11.5L Shares on Warrant Conversion

Novelix Pharmaceuticals' board on March 30, 2026 approved allotment of 11,50,000 equity shares at Rs. 20 each via promoter warrant conversion.
Allottees are Srinidhi Fine-Chemicals LLP (11,00,000 shares) and Narahari Belide (50,000 shares) from the promoter and promoter group category.
Paid-up equity capital increased from Rs. 1,99,35,000 to Rs. 2,10,85,000 following this allotment of 11,50,000 shares.
Out of 1,50,00,000 total warrants allotted in January 2025, cumulative conversion now stands at 88,15,000 warrants post this tranche.